A TP53 Related Immune Prognostic Model for the Prediction of Clinical Outcomes and Therapeutic Responses in Lung Adenocarcinoma.
Zhang X, Min S, Yang Y, Ding D, Li Q, Liu S, Tao T, Zhang M, Li B, Zhao S, Ge R, Yang F, Li Y, He X, Ma X, Wang L, Wu T, Wang T, Wang G.
Zhang X, et al. Among authors: wang g, wang l, wang t.
Front Immunol. 2022 Jun 28;13:876355. doi: 10.3389/fimmu.2022.876355. eCollection 2022.
Front Immunol. 2022.
PMID: 35837383
Free PMC article.